跳至主要内容
临床试验/NCT04054219
NCT04054219Unknown不适用

Prospective, Single Center, Pivotal Investigation to Investigate Efficacy and Safety of WISHBONE HA, Used as Bone Graft Substitute for Different Indications Where Bone Grafting Procedures Are Required Before Implant Placement.

Wishbone SA1 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2019年7月8日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
47
试验地点
1
主要终点
Measure of the bone augmentation success

研究概览

简要总结

Evaluation of efficacy and safety of Wishbone HA as bone graft substitute, a pre-market clinical investigation.

Group1: Extraction Socket management Group 2: Sinus lift

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subject signed the informed consent form
  • •Subject is ≥18 and ≤ 80 years old.
  • •Subject presented in need of:
  • •tooth extraction without estimated need of connective tissue grafting OR
  • •defect in the upper jaw requiring sinus lift with or without lateral augmentation procedure prior to implant placement
  • •The subject is willing and able to comply with all investigation related procedures (such as exercising oral hygiene and attending all follow-up visits).
  • •Full-mouth bleeding score (FMBS) lower than 25%
  • •Full-mouth plaque score (FMPI) lower than 25%
  • •The subject displays no clinical contraindications for a 2-stage surgical procedure

排除标准

  • •Less than 2 mm of remaining keratinized mucosa
  • •Severe vertical resorption of the crest (except internal resorptions, i.e. expanded sinuses)
  • •Ridge with prior bone augmentation procedure performed (i.e ridge preservation)
  • •Any disorders in the planned implant area such as previous tumors, chronic bone disease.
  • •Alcohol or drug abuse as noted in subject records or in subject history.
  • •Any ongoing application of interfering medication (steroid therapy, bisphosphonate, etc).
  • •Reason to believe that the treatment might have a negative effect on the subject's overall situation (psychiatric problems), as noted in subject records or history.
  • •Smoking: >10 cigarettes per day

结局指标

主要结局

Measure of the bone augmentation success

时间窗: 6 months after procedure

Group 2 - Sinus lift: Efficacy endpoint based on the bone augmentation success (bone gain after bone augmentation procedure) measured by Cone Beam CT

Measure of the bone augmentation success

时间窗: 4 months after procedure

Group 1 - Extraction Socket Management: Efficacy endpoint based on the bone augmentation success (bone gain after bone augmentation procedure) measured by Cone Beam CT

次要结局

  • Implant success(1 year after after definitive prosthesis delivery)
  • Papilla index evaluation(1 year after definitive prosthesis delivery)
  • Plaque index evaluation(1 year after definitive prosthesis delivery)
  • Patient Oral health profile evaluation(1 year follow-up visit)
  • Implant survival(1 year after after definitive prosthesis delivery)
  • Procedure success: ability to successfully perform the implants placement(6 months after procedure)
  • Assessment of the bone quality and bone quantity(6 months after procedure)
  • Safety endpoint: Collection of all device related adverse events(6 months after procedure)
  • Site preparation: need for under or over preparation of the osteotomy(6 months after procedure)
  • Keratinized mucosa evaluation(1 year after definitive prosthesis delivery)
  • Bleeding index evaluation(1 year after definitive prosthesis delivery)
  • Safety endpoint: Collection of all device related adverse events(4 months after procedure)
  • Procedure success: ability to successfully perform the implants placement(4 months after procedure)
  • Site preparation: need for under or over preparation of the osteotomy(4 months after procedure)
  • Assessment of the bone quality and bone quantity(4 months after procedure)

研究者

发起方
Wishbone SA
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验